Supplemental Treatment for Huntington’s Disease with miR-132 that Is Deficient in Huntington’s Disease Brain
نویسندگان
چکیده
1Department of Molecular Pharmacology, National Institute of Neuroscience, NCNP, Tokyo, Japan; 2Division of RNA Medical Science, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan; 3Department of Degenerative Neurological Diseases, National Institute of Neuroscience, NCNP, Tokyo, Japan; 4Department of Molecular Therapy, National Institute of Neuroscience, NCNP, Tokyo, Japan; 5National Center Hospital, NCNP, Tokyo, Japan; 6Oomuta Hospital, Fukuoka, Japan
منابع مشابه
Symptomatic Treatment and Management of Huntington’s Disease: An Overview
Huntington’s disease (HD) is an inherited disease of the central nervous system that usually has its onset between 30 and 50 years of age. The patient has progressive dementia with bizarre involvantary movements of chorea. The disease slowly progresses and death is usually due to an intercurrent infection. Huntington’s disease affects someone’s ability to think, talk and move by destroying cell...
متن کاملExpandable DNA Repeat and Human Hereditary Disorders
Background & Aims: Nearly 30 hereditary disorders in humans result from an increase in the number of copies of simple repeats in genomic DNA, including fragile X syndrome, myotonic dystrophy, Huntington’s disease, and Friedreich’s ataxia. One the most frequently occurring types of mutation is trinucleotide repeat expansion. The present study was conducted with the aim of investigating the cause...
متن کاملSCIENTIFIC COMMENTARY Huntington’s disease: fighting on many fronts
The discovery in 1993 of the genetic abnormality that causes Huntington’s disease triggered an explosion in our understanding of this inherited neurodegenerative disorder (The Huntington’s Disease Collaborative Research Group, 1993). Since the Huntington’s disease mutation is fully penetrant, everyone with the same underlying CAG triplet repeat expansion in the huntingtin (HTT) gene will develo...
متن کاملEPA and Huntington's chorea: treatment and associated cerebral changes
Huntington’s disease (Huntington’s chorea) is an autosomal dominant disease of the human brain caused by an unstable expansion of CAG trinucleotide triplet repeats in the huntingtin gene at 4p16.3; the CAG repeats are transcribed and translated into polyglutamine expansion (polyQ) stretches, and the length of the repeats correlates inversely with age of onset. Huntington’s disease is characteri...
متن کاملOp-brai150270 1..18
Huntington’s disease can be predicted many years before symptom onset, and thus makes an ideal model for studying the earliest mechanisms of neurodegeneration. Diffuse patterns of structural connectivity loss occur in the basal ganglia and cortex early in the disease. However, the organizational principles that underlie these changes are unclear. By understanding such principles we can gain ins...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره 11 شماره
صفحات -
تاریخ انتشار 2018